Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New treatment to beat severe incontinence

28.10.2003


Scientists have developed a potential treatment for severe incontinence that means the millions of sufferers worldwide could one day throw away their incontinence pads.



University of Melbourne scientists, who developed the technique, have now licensed the intellectual property to Continence Control Systems International P/L (CCS), an Australian company created to commercialise the technology that will address a worldwide potential market of more than A$1 billion per year.

Urinary incontinence is the involuntary loss of urine from the bladder. The research team from three University departments (Anatomy, Zoology and Surgery) has found a way of creating a ring of muscle from the patient’s own body and transplanting it to the bladder where it acts as a replacement sphincter. One of the causes of the most common type of urinary incontinence, known as stress incontinence, is when the sphincter muscle no longer dependably keeps urine in the bladder.


The replacement sphincter is controlled by an implanted electrical stimulator that should, for the first time, give sufferers of severe stress incontinence, a reliable method of passing urine only when they want. Under terms of an exclusive supply agreement with CCS, the necessary implanted technology will be provided by Cochlear Limited.

"The only surgical solutions available until now have involved prosthetic devices that have had problems with leakage, failure and adverse tissue reactions," says University of Melbourne’s Professor John Furness and one of the inventors of the treatment.

"This treatment has the potential to revolutionise the management of severe urinary incontinence which afflicts tens of thousands of people worldwide. This is a miserable condition, and if not effectively managed, can result in people entering nursing homes or institutions because they are unable to cope," he says.

"The most common cause of a defective sphincter muscle is trauma to the area, for example as a complication of prostate surgery in men, or more frequently in women as they reach menopause, particularly if they have had children," says Furness.

CCS will seek to raise up to $A8M in equity funds to complete the development work leading to clinical trials in 2005, which if successful, will result in a commercial product available for sale within five years.

"The number of people suffering from this condition means there is a large potential market. This research breakthrough by the University and access to Cochlear’s technology creates a partnership of two of Australia’s greatest innovators, which will accelerate the development program," says CEO of CCS, Mr Tony Stephens.

The capital raising is being conducted by Nextec BioSciences, a Melbourne based Investment Banking Company specialising in the Biotechnology sector.

Jason Major | University of Melbourne
Further information:
http://uninews.unimelb.edu.au/articleid_1016.html

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>